Abstract CT233: Treatment of neurofibromatosis type 1 (NF1)-related plexiform neurofibromas (PN) with cabozantinib (XL184): A Neurofibromatosis Clinical Trials Consortium Phase II trial
Year: 2019
Type: conference-abstract
Source: Cancer Research
Authors: Chie-Schin Shih, Jaishri Blakeley, D. Wade Clapp, Amy E. Armstrong, Pam Wolters, Eva Dombi, Gary Cutter, Nicole J. Ullrich, Jeffrey Allen, Roger Packer, Stewart Goldman, David H. Gutmann, Scott Plotkin, Tena Rosser, Kent Robertson, Brigitte Widemann, Steven Rhodes, Steven Angus, Gary Johnson, Bruce Korf, Michael J. Fisher
Institutions: Riley Hospital for Children, Johns Hopkins University, Johns Hopkins Medicine, Johns Hopkins Hospital, National Cancer Institute, University of Alabama at Birmingham, Boston Children's Hospital, New York University, Children's National, Lurie Children's Hospital, Washington University in St. Louis, Massachusetts General Hospital, Children's Hospital of Los Angeles, University of North Carolina at Chapel Hill, Children's Hospital of Philadelphia
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2956089583